Skip to content

A multi-center study for the diagnosis and treatment of Posner Schlossmann syndrome

A multi-center study for the diagnosis and treatment of Posner Schlossmann syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024680
Enrollment
Unknown
Registered
2019-07-20
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posner Schlossmann syndrome

Interventions

treatment group ( grouped by different regions, withdrawal time and cytomegalovirus infection):anti inflammation, IOP lowering, anti-virus.

Sponsors

Eye and ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Posner-Schlossman syndrome patients, with recurrent elevated intraocular pressure higher than 21mmHg during attack periods and normal intraocular pressure between attack periods, very mild inflammation within anterior chamber, presence of kp and open angle. The intraocular pressure, visual field and optic disc of the unaffected eye is normal. 2) Aged older than 18 years. 3) Consented to attend the study.

Exclusion criteria

Exclusion criteria: 1) Patients with primary glaucoma or elevated intraocular pressure due to other causes. 2) Other ocular disease, including retinal disease, corneal disease, ocular trauma or inflammation. 3) Patients who has underwent anti-glaucoma surgery before admission. 4) Allergic to steroid, antiglaucoma drugs, or ganciclovir. 5) Existence of hepatorenal insufficiency or hematological diseases. 6) Pregnant of breasting female.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;inflammation;

Countries

China

Contacts

Public ContactKong Xiangmei

Eye and ENT Hospital of Fudan University

kongxm95@163.com+86 13817890921

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026